Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

The Chi-PCOSQ is effective for assessing health-related quality of life in Chinese women with PCOS.

Computational techniques can improve drug development for treating certain conditions.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Androgenetic alopecia negatively impacts quality of life, especially for women, due to social reactions.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Rivaroxaban may cause hair loss.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

A gene network led by RSL4 is crucial for early root hair growth in response to cold in Arabidopsis thaliana.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Gene expression affects fur development in rex rabbits.

Understanding patients' views on their illness can help improve their disease management.

Biosea® Revive Serum is safe and effective for improving hair growth and health.

Key genes and RNA networks regulate hair growth and follicle density in Rex rabbits.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Primary cicatricial alopecia significantly reduces life quality, mainly due to pain and anxiety.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

OsRopGEF3 is crucial for rice root hair growth and ROS production.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.